Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-29 Purchase | 2024-06-07 9:45 pm | GENELUX Corp | GNLX | Smither John W Director | 6,250 | $0 | $0 | 19,420 (Direct) | View |
| 2023-09-13 Sale | 2023-09-14 8:18 pm | GENELUX Corp | GNLX | Smither John W Director | 900 | $20.78 | $18,702 | 6,920 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-07 Option Award | 2026-01-09 7:33 pm | N/A 2036-01-07 | NewAmsterdam Pharma Co N.V. | NAMS | Smither John W Director | 18,700 | $0 | 25,660 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Smither John W Director | 50,859 | $0 | 103,570 (Direct) | View |
| 2025-01-06 Option Award | 2025-01-08 6:09 pm | N/A 2035-01-06 | NewAmsterdam Pharma Co N.V. | NAMS | Smither John W Director | 39,460 | $0 | 39,460 (Direct) | View |
| 2024-08-01 Option Award(A) | 2024-12-31 1:20 pm | N/A 2034-07-31 | GENELUX Corp | GNLX | Smither John W Director | 50,469 | $0 | 50,469 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-05 6:34 pm | N/A 2034-07-31 | GENELUX Corp | GNLX | Smither John W Director | 90,010 | $0 | 103,180 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 6:23 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 11,365 | $0 | 152,757 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:13 pm | N/A 2034-01-01 | NewAmsterdam Pharma Co N.V. | NAMS | Smither John W Director | 10,000 | $0 | 10,000 (Direct) | View |
Ownership | 2023-12-29 4:30 pm | N/A 2033-01-14 | NewAmsterdam Pharma Co N.V. | NAMS | Smither John W Director | 0 | $0 | 18,600 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 8:14 pm | N/A 2033-09-10 | GENELUX Corp | GNLX | Smither John W Director | 15,367 | $0 | 16,267 (Direct) | View |
Ownership | 2023-09-13 8:13 pm | N/A N/A | GENELUX Corp | GNLX | Smither John W Director | 0 | $0 | 900 (Direct) | View |
| 2023-08-31 Option Award | 2023-09-05 9:38 pm | N/A 2033-08-31 | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
Ownership | 2023-09-05 9:36 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Smither John W Chief Financial Officer | 0 | $0 | 253,738 (Indirect) | View |
| 2023-06-22 Option Award | 2023-06-22 8:16 pm | N/A 2033-06-21 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 5:28 pm | N/A 2033-06-14 | Applied Molecular Transport Inc. | AMTI | Smither John W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:15 pm | N/A 2033-01-19 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 36,875 | $0 | 36,875 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 6:51 pm | N/A 2032-06-08 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 5:23 pm | N/A 2032-05-24 | Applied Molecular Transport Inc. | AMTI | Smither John W Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 5:39 pm | 2022-02-27 2032-01-27 | Applied Molecular Transport Inc. | AMTI | Smither John W Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2021-10-06 Option Award | 2021-10-08 5:18 pm | N/A 2031-10-05 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-08-25 Option Award | 2021-08-27 6:26 pm | N/A 2028-03-26 | eFFECTOR Therapeutics Inc. | EFTR | Smither John W Director | 27,698 | $0 | 51,840 (Direct) | View |